Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 7 | BES2004 | Next issue

23rd Joint Meeting of the British Endocrine Societies with the European Federation of Endocrine Societies

Oral Communications

Diabetes and metabolism

ea0007oc31 | Diabetes and metabolism | BES2004

Inducing pancreatic beta cell regeneration; interactions of transcription factors and peptide growth factors

Leadbeater W , Thyssen S , Strutt B , Chamson A , Arany E , Pin C , Logan A , Hill D

Pancreatic islet cell transplantation is proven to restore functional beta cell mass to achieve normoglycemia in diabetics, but is limited by low availability of human cadaveric donor tissue. A strategy to build capacity is to use stem cells (SCs), and induce their expansion and differentiation into functional islets in vitro. Islet cell neogenesis has been linked to transient and sequential expression of specific transcription factors (TFs) and the actions of endogenou...

ea0007oc32 | Diabetes and metabolism | BES2004

Function of the calcium-sensing receptor in insulin-secreting MIN6 cells and human islets of Langerhans

Squires P , Gray E , Huang G , Amiel S , Persaud S , Jones P

Objective: The extracellular calcium-sensing receptor (CaR) is expressed on many different cell types other than those involved in the systemic regulation of plasma calcium. We have demonstrated previously that insulin-producing beta cells express the CaR. In this study we have used a calcimimetic CaR agonist (A568) to investigate the effects of CaR activation on beta cell function.Methods: Experiments used the insulin secreting MIN6 cell line or isolate...

ea0007oc33 | Diabetes and metabolism | BES2004

Dietary intake and the IGF-system: a study in two related populations with a markedly different dietary intake

Anderson S , Heald A , Vyas A , Siddals K , Patel J , Laing I , Bhatnagar D , Durrington P , Gibson J , Cruickshank J

IntroductionThe IGF-system has also been implicated in the pathogenesis of diabetes and cardiovascular disease. We report the effects of total energy intake on the IGF-system in two populations with a markedly different dietary macronutrient intake and cardiovascular event rate.MethodDietary macronutrient intake was measured in a specific Gujarati migrant community in Sandwell UK (n=205) compared with people ...

ea0007oc34 | Diabetes and metabolism | BES2004

POMC haploinsufficiency in mice can cause obesity and reduced adrenal function

Coll A , Challis B , Yeo G , Snell K , O'Rahilly S

Pro-opiomelanocortin (POMC) deficiency in mice and humans results in a syndrome of severe obesity, hyperphagia and adrenal insufficiency. We have used mice heterozygous for a null mutation in the Pomc allele (Pomc+/-) to determine if POMC haploinsufficiency results in disordered energy homeostasis or adrenal hypofunction.When fed standard lab diet (SLD, 4.5% fat) Pomc+/-were similar in weight to wild type (WT) mice thr...

ea0007oc35 | Diabetes and metabolism | BES2004

Continuous subcutaneous administration of ghrelin results in accumulation of adipose tissue, independent of hyperphagia or body weight gain

Wren A , Small C , Thomas E , Abbott C , Ghatei M , Bell J , Bloom S

Ghrelin, a circulating gastric hormone, stimulates food intake in rodents and humans and hyperphagia, weight gain and adiposity on chronic administration in rodents. Here we investigated the effect of chronic subcutaneous ghrelin on fat volume and distribution using magnetic resonance imaging (MRI). Male Wistar rats were implanted with subcutaneous osmotic mini-pumps delivering saline (S, n=10) or ghrelin 30nmol/24hours (n=18). In order to investigate the hyperphagia-independe...

ea0007oc36 | Diabetes and metabolism | BES2004

Tissue-specific alterations of glucocorticoid metabolism in ob/ob mice

Livingstone D , Packer S , Kerr R , Morton N , Walker B , Andrew R

Glucocorticoid metabolism is altered in a tissue-specific manner in obesity. Increased reactivation of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 (11HSD1) amplifies glucocorticoid action in abdominal fat, whereas increased metabolism of glucocorticoids by hepatic A-ring reductases may contribute to activation of the hypothalamic-pituitary-adrenal axis. These changes have been characterised in leptin-resistant obese Zucker rats and obese humans. Here we inves...

ea0007oc37 | Diabetes and metabolism | BES2004

Resistin as an acute phase reactant and a positive mediator of IL-6 and TNF-alpha secretion in isolated human subcutaneous adipocytes

Kusminski C , McTernan P , Fisher F , Valsamakis G , Chetty R , Harte A , Kumar S

Chronic sub-clinical inflammation is associated with both type 2 diabetes and related vascular complications which is coupled with pro-inflammatory markers, such as IL-6, TNF-alpha and C-reactive protein (CRP). Resistin is the latest protein to be linked with inflammation and insulin resistance in obesity. Adipose tissue has been previously established as a source of circulating resistin, TNF-alpha and IL-6. As our previous studies demonstrated a correlation between serum resi...

ea0007oc38 | Diabetes and metabolism | BES2004

Bacterial and yeast co-expression studies reveal hexose-6-phosphate dehydrogenase to be a crucial regulator of 11beta-hydroxysteroid dehydrogenase type 1 oxoreductase activity

Walker O , Schneider S , Edelstein M , Walker E , Arlt W , Stewart P

11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) has been implicated in the pathogenesis of human obesity and insulin resistance through 11-oxoreductase activation of cortisol (F) from cortisone (E) stimulating adipocyte differentiation and hepatic glucose output. In its purified state however, 11beta-HSD1 is a dehydrogenase inactivating F to E. In patients with cortisone reductase deficiency we recently identified two inactivating mutations, delta29bp and R453Q, withi...